| Dobutamine stress myocardial perfusion imaging in coronary artery disease. | |
| | |
MedLine Citation:
|
PMID: 12468513 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The accurate noninvasive diagnosis and functional evaluation of coronary artery disease is an important step in selecting the appropriate management strategy. Dobutamine stress myocardial perfusion imaging is an alternative to exercise in patients with limited exercise capacity. In many centers, the test is performed on patients who have a contraindication for vasodilator stress testing. Recent studies have shown hyperemia induced by the standard dobutamine-atropine stress test is not less than hyperemia induced by dipyridamole. The feasibility of the test is 90% and is often higher in patients without beta-blocker therapy. The safety of the test has been well studied and was also demonstrated in specific patients groups, such as patients with left ventricular dysfunction, the elderly, and heart transplant recipients. The diagnostic accuracy has been demonstrated in patients with and without myocardial infarction and in specific groups such as those with hypertension, left ventricular hypertrophy, and heart transplant recipients and after revascularization. The technique has a high sensitivity for prediction of functional recovery in patients with myocardial dysfunction referred for revascularization. The presence and severity of myocardial perfusion abnormalities assessed by this method are powerful predictors of cardiac events, incremental to clinical data. This article describes the methodology, safety, feasibility, diagnostic accuracy, and prognostic value of dobutamine stress myocardial perfusion imaging in patients with known or suspected coronary artery disease, with additional considerations for the application of the test in specific patient groups. |
| | |
Authors:
|
Abdou Elhendy; Jeroen J Bax; Don Poldermans |
Related Documents
:
|
8823003 - Contractile versus microvascular reserve for the determination of the extent of myocard... 7641353 - Incremental doses of dobutamine induce a biphasic response in dysfunctional left ventri... 23434443 - Pineal calcification is associated with symptomatic cerebral infarction. |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Journal of nuclear medicine : official publication, Society of Nuclear Medicine Volume: 43 ISSN: 0161-5505 ISO Abbreviation: J. Nucl. Med. Publication Date: 2002 Dec |
Date Detail:
|
Created Date: 2002-12-06 Completed Date: 2003-01-10 Revised Date: 2005-11-16 |
Medline Journal Info:
|
Nlm Unique ID: 0217410 Medline TA: J Nucl Med Country: United States |
Other Details:
|
Languages: eng Pagination: 1634-46 Citation Subset: IM |
Affiliation:
|
University of Nebraska Medical Center, Omaha, Nebraska 68198-2055, USA. aelhendy@unmc.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Angioplasty, Transluminal, Percutaneous Coronary Coronary Circulation* Coronary Disease / radionuclide imaging* Dobutamine / diagnostic use* Echocardiography Electrocardiography Heart / radionuclide imaging* Heart Rate Heart Transplantation Humans Organophosphorus Compounds / diagnostic use Organotechnetium Compounds / diagnostic use Tomography, Emission-Computed, Single-Photon |
| Chemical | |
Reg. No./Substance:
|
0/Organophosphorus Compounds; 0/Organotechnetium Compounds; 0/technetium Tc 99m 1,2-bis(bis(2-ethoxyethyl)phosphino)ethane; 34368-04-2/Dobutamine |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Effects of methylphenidate discontinuation on cerebral blood flow in prepubescent boys with attentio...
Next Document: Sigma receptor scintigraphy with N-[2-(1'-piperidinyl)ethyl]-3-(123)I-iodo-4-methoxybenzamide of pat...